With gene therapy, a cure for growth-hormone resistant dwarfism may be on the horizon. National University of Singapore, Yong Loo Lin School of Medicine Researchers from the NUS Yong Loo Lin School of ...

A novel drug for the most common cause of dwarfism accelerated children’s growth in a small but closely watched clinical trial, the company BridgeBio said Monday, advancing the latest treatment in ...

Oct 20 (Reuters) - The U.S. health regulator on Friday approved the expanded use of BioMarin Pharmaceutical's (BMRN.O), opens new tab once-daily injection to treat children under the age of 5 with the ...

The Food and Drug Administration approved the first treatment for the most common cause of dwarfism Friday, a drug that has proved to increase children’s height but has been polarizing among adults ...

Rare growth disorders are a diverse group of uncommon conditions that affect an individual’s physical development. They may stem from genetic mutations, hormonal imbalances, or other complex factors.

A genetic disorder that slows bone growth and leads to dwarfism now has an approved drug, a biologic therapy developed by BioMarin Pharmaceutical. The European Commission decision announced Friday ...

The Food and Drug Administration (FDA) announced Friday that it had approved a drug for children with achondroplasia, the most common form of dwarfism. The drug, Voxzogo, is an injection to improve ...

Shauna Rae is a 23-year-old woman stuck in an eight-year-old's body. At just three feet, 10 inches tall, the reality star's growth was stunted due to treatment she received for brain cancer as a child ...

Fifty years ago this week, Apollo 12 landed on the surface of the moon. But it seems this moon mission is overshadowed by the more famous Apollo 11 and Apollo 13 landings. NPR's Geoff Brumfiel reports ...